NEW YORK, NY / ACCESS Newswire / February 2, 2026 / Iron Dome Acquisition I Corp. ("IDAC"), a blank check company ...

Eikon Therapeutics and Veradermics have gone public, with other biotechs poised to stage IPOs.

Agomab Therapeutics NV (Nasdaq: AGMB) ('Agomab”), a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an ...

NSE formally approved its IPO and cleared the formation of an IPO committee to oversee and execute the listing process. Such a panel is mandatory for companies without promoters looking to go public.

Eikon Therapeutics, Inc. ('Eikon”), a late-stage clinical biopharmaceutical company dedicated to developing important, ...

Veradermics Inc., a late clinical-stage biopharmaceutical company focused on hair restoration, raised $256.3 million in an ...

NEW YORK, NY / ACCESS Newswire / January 29, 2026 / On January 28, 2026, GigCapital9 Corp. closed its Initial Public ...

Eight companies are targeting a collective $3.9 billion in what’s set to be the busiest week for US initial public offerings ...

The record-setting transaction is the largest merger of all time and values SpaceX at $1 trillion and xAI at $250 billion, ...

Once Upon a Farm today announced the pricing of its initial public offering of 10,997,209 shares of its common stock, 7,631,537 shares of which are being offered by Once ...

Elon Musk is joining his space exploration and artificial intelligence ventures into a single company before a massive ...

In 2025, the initial public offering (IPO) market continued to rebound from the 2022 and 2023 slump. For the second year in a row, markets saw more IPOs, more special purpose acquisition companies ...